BioNTech Results Presentation Deck

A Leading Provider Globally of COVID-19 Vaccines: -2.2 bn Bn Doses Contracted for 2021* ● Selected Regions ● EU US Other 2021 Orders TOTAL 660 m 410 m -1.150 m Expanding Access to Low & Middle-Income Countries ~2.2 bn 2022 and Beyond > 1 bn (excl. options) Ongoing discussions for additional doses in 2021/2022 and beyond. 900 m doses (plus option for additional 900 m) 90 m Canada, Israel and others 13 *As of July 21, 2021; In combination with contracts entered into by Pfizer 2 bn doses pledged over the next 18 months to ensure global equitable vaccine access Plans to provide 500 m doses to U.S. government for donation to ~100 countries, including those in African Union via COVAX BIONTECH

View entire presentation